MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method

Some patients with advanced colon adenocarcinoma (COAD) are not sensitive to radiotherapy and chemotherapy, and as such, immunotherapy has become the most popular option for these patients. However, different patients respond differently to immunotherapy. Tumor mutational burden (TMB) has been used...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhengtian, Jiang, Lingling, Zhao, Rong, Huang, Jun, Yang, Wenkang, Wen, Zhenpei, Zhang, Bo, Du, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154456/
https://www.ncbi.nlm.nih.gov/pubmed/34032736
http://dx.doi.org/10.1097/MD.0000000000026068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154456/
https://www.ncbi.nlm.nih.gov/pubmed/34032736
http://dx.doi.org/10.1097/MD.0000000000026068

Ejemplares similares